{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:33:39Z","timestamp":1761744819428,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.dsx.2020.04.040","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T01:30:42Z","timestamp":1588642242000},"page":"509-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review"],"prefix":"10.1016","volume":"14","author":[{"given":"Afif","family":"Nakhleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Shehadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.dsx.2020.04.040_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5619","article-title":"Clinical characteristics of patients who died of coronavirus disease 2019 in China","volume":"3","author":"Xie","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.040_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"issue":"22","key":"10.1016\/j.dsx.2020.04.040_bib3","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-\u03b1-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-\u03b1 production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.dsx.2020.04.040_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2020.04.040_bib5","first-page":"181","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.dsx.2020.04.040_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.dsx.2020.04.040_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A\u00a0novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"issue":"7047","key":"10.1016\/j.dsx.2020.04.040_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2020.04.040_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic renin-angiotensin systems in the critically ill [internet]","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit Care Clin"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.040_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.metabol.2014.11.004","article-title":"ACE2 deficiency shifts energy metabolism towards glucose utilization","volume":"64","author":"Bernardi","year":"2015","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.dsx.2020.04.040_bib11","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"Bindom","year":"2010","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.dsx.2020.04.040_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2337\/db12-0177","article-title":"Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice","volume":"62","author":"Takeda","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2020.04.040_bib13","first-page":"193","volume":"vol. 302","author":"Bindom","year":"2009"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.040_bib14","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00391.2007","article-title":"High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes","volume":"293","author":"Singh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.dsx.2020.04.040_bib15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/CIRCRESAHA.112.268029","article-title":"Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II\/AT1 receptor axis","volume":"110","author":"Patel","year":"2012","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.dsx.2020.04.040_bib16","doi-asserted-by":"crossref","first-page":"C767","DOI":"10.1152\/ajpcell.00247.2014","article-title":"Functional and molecular evidence for expression of the renin angiotensin system and ADAM17-mediated ACE2 shedding in COS7 cells","volume":"308","author":"Grobe","year":"2015","journal-title":"Am J Physiol - Cell Physiol [Internet]"},{"issue":"1","key":"10.1016\/j.dsx.2020.04.040_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085958","article-title":"Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells","volume":"9","author":"Xiao","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.040_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-12-0782","article-title":"High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria","volume":"168","author":"Park","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.040_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.dsx.2020.04.040_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.23250","article-title":"Increased tumor necrosis factor \u03b1-converting enzyme activity induces insulin resistance and hepatosteatosis in mice","volume":"51","author":"Fiorentino","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2020.04.040_bib21","doi-asserted-by":"crossref","first-page":"152410","DOI":"10.1016\/j.prp.2019.04.002","article-title":"The metalloprotease ADAM17 in inflammation and cancer","volume":"215","author":"D\u00fcsterh\u00f6ft","year":"2019","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.dsx.2020.04.040_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00109-003-0450-y","article-title":"Inflammatory mediators and islet \u03b2-cell failure: a link between type 1 and type 2 diabetes","volume":"81","author":"Donath","year":"2003","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.dsx.2020.04.040_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.dsx.2020.04.040_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","article-title":"Recombinant human ACE2: Acing out angiotensin II in ARDS therapy","volume":"21","author":"Zhang","year":"2017","journal-title":"Critical Care. BioMed Central"},{"issue":"5","key":"10.1016\/j.dsx.2020.04.040_bib25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00134-007-0978-3","article-title":"Early versus late intravenous insulin administration in critically ill patients","volume":"34","author":"Honiden","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.dsx.2020.04.040_bib26","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/CCM.0b013e3181a0fea5","article-title":"Diabetes, insulin, and development of acute lung injury [Internet]","volume":"37","author":"Honiden","year":"2009","journal-title":"Critical Care Medicine. Lippincott Williams and Wilkins"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.040_bib27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/01.CCM.0000201902.37115.22","article-title":"Insulin attenuates endotoxin-induced acute lung injury in conscious rats","volume":"34","author":"Chen","year":"2006","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.dsx.2020.04.040_bib28","doi-asserted-by":"crossref","first-page":"F629","DOI":"10.1152\/ajprenal.00516.2013","article-title":"Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice","volume":"306","author":"Salem","year":"2014","journal-title":"Am J Physiol Physiol"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.040_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030563","article-title":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse","volume":"18","author":"Roca-Ho","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.040_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.200710-1602OC","article-title":"Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury","volume":"178","author":"Zmijewski","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.dsx.2020.04.040_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: current perspectives on causes and risk","volume":"65","author":"Defronzo","year":"2016","journal-title":"Metabolism: Clinical and Experimental. W.B. Saunders"},{"issue":"2","key":"10.1016\/j.dsx.2020.04.040_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00091011","article-title":"Pioglitazone attenuates endotoxin-induced acute lung injury by reducing neutrophil recruitment","volume":"40","author":"Grommes","year":"2012","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.dsx.2020.04.040_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062833","article-title":"Rosiglitazone treatment of type 2 diabetic db\/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion. Bader M","volume":"8","author":"Chodavarapu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.dsx.2020.04.040_bib34","article-title":"Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis","volume":"2014","author":"Zhang","year":"2014","journal-title":"Sci World J"},{"issue":"5","key":"10.1016\/j.dsx.2020.04.040_bib35","doi-asserted-by":"crossref","first-page":"L834","DOI":"10.1152\/ajplung.00031.2018","article-title":"DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice","volume":"315","author":"Kawasaki","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.040_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.diabres.2013.12.039","article-title":"The dipeptidyl peptidase-4 inhibitor vildagliptin does not affect ex\u00a0vivo cytokine response and lymphocyte function in patients with type 2 diabetes mellitus","volume":"103","author":"Van Poppel","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"7440","key":"10.1016\/j.dsx.2020.04.040_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2020.04.040_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3601454","article-title":"GLP-1 analogue liraglutide enhances SP-A expression in LPS-induced acute lung injury through the TTF-1 signaling pathway","volume":"2018","author":"Zhu","year":"2018","journal-title":"Mediat Inflamm"},{"issue":"10","key":"10.1016\/j.dsx.2020.04.040_bib40","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1210\/en.2014-1685","article-title":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats","volume":"156","author":"Roman\u00ed-P\u00e9rez","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2020.04.040_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.12548","article-title":"Empagliflozin attenuates transient cerebral ischemia\/reperfusion injury in hyperglycemic rats via repressing oxidative\u2013inflammatory\u2013apoptotic pathway","author":"Amin","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.dsx.2020.04.040_bib42","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.dsx.2020.04.040_bib44","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2147\/DDDT.S196040","article-title":"Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway","volume":"13","author":"Chen","year":"2019","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.dsx.2020.04.040_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3578702","article-title":"A\u00a0Protective Role of Glibenclamide in Inflammation-Associated Injury","volume":"2017","author":"Zhang","year":"2017","journal-title":"Mediat Inflamm"},{"issue":"3","key":"10.1016\/j.dsx.2020.04.040_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2337\/diaspect.27.3.180","article-title":"Pharmacotherapy for hyperglycemia in noncritically ill hospitalized patients","volume":"27","author":"Mendez","year":"2014","journal-title":"Diabetes Spectr"},{"volume":"vol. 43","year":"2020","author":"Association","key":"10.1016\/j.dsx.2020.04.040_bib47"},{"key":"10.1016\/j.dsx.2020.04.040_bib48","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s13300-018-0488-z","article-title":"Safety and efficacy of DPP4 inhibitor and basal insulin in type 2 diabetes: an updated review and challenging clinical scenarios","volume":"9","author":"Gomez-Peralta","year":"2018","journal-title":"Diabetes Therapy. Springer Healthcare"},{"issue":"7","key":"10.1016\/j.dsx.2020.04.040_bib49","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2337\/dc12-2060","article-title":"Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes? the time has come for GLP-1 receptor agonists!","volume":"36","author":"Schwartz","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402120301053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:15:34Z","timestamp":1761729334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402120301053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1871402120301053"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2020.04.040","relation":{},"ISSN":["1871-4021"],"issn-type":[{"type":"print","value":"1871-4021"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2020.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}